Sangita Choudhary1, Rajesh Kumar2
BACKGROUND
Diabetes mellitus is disorder of metabolism characterised by chronic hyperglycaemia resulting from an absolute/relative insufficiency of insulin secretion, insulin action or most commonly both.1 Type 2 diabetes is more common and account for 90-95% of diabetic patient.2 Severity of diabetes triggers a vast group of complications, both microvascular or macrovascular.3
MATERIALS AND METHODS
Glycosylated Haemoglobin (HbA1c) is a form of haemoglobin, which used primarily to identify the average plasma glucose concentration over prolonged periods of time (8 to 12 weeks).4 The early diagnosis and glycaemic control in diabetes mellitus is important because control of blood sugar level can reduce the risk of long-term complications (Babcock Irvin C, et al; 2000)5 and may improve treatment (Larsen ML, et al; 1990).4
RESULTS AND CONCLUSION
The primary aim of this work is to establish the role of HbA1c in monitoring the progression of disease and glycaemic control in diabetic patients.
